🔗 Visit the ClinicalTrials.gov page for NCT00077454
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The rationale for targeted therapies in medulloblastoma. | Neuro Oncol | 2013 | 0.92 |
| 2 | Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. | Stem Cells Int | 2016 | 0.81 |
| 3 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |
| 4 | Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines. | PLoS One | 2015 | 0.75 |